Quaker Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
ETC
Quaker Wealth Management's BMY Position: Q2 2026 in Review
Quaker Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 12% in Q2 2026, buying an estimated $12.8K and bringing the position to 2,138 shares worth $123K. The position accounts for 0.04% of the portfolio, ranked #98.
Quaker Wealth Management first reported a position in BMY in Q4 2019 and has held it in 16 quarters since. The position peaked at $344K in Q3 2023. 832 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Quaker Wealth Management held 2,138 shares of Bristol-Myers Squibb worth $123K as of Q2 2026.
- Quaker Wealth Management bought 223 Bristol-Myers Squibb shares in Q2 2026, an estimated $12.8K.
- Bristol-Myers Squibb made up 0.04% of Quaker Wealth Management's portfolio in Q2 2026, its #98 holding.
- Quaker Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 16 quarters since.
- Quaker Wealth Management's Bristol-Myers Squibb position peaked at $344K in Q3 2023.
- 832 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Quaker Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.